Investor Relations

Corporate Profile

Avenue Therapeutics, Inc., a Fortress Biotech Company, is a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes products for use in acute healthcare or hospital settings. Avenue’s lead product candidate is intravenous (IV) tramadol for the management of post-operative pain. The company plans to initiate a Phase III development program of IV tramadol in 2017. Avenue is headquartered in New York City.

Stock Quote

NASDAQ: ATXI 4.48 -0.25 -5.29%
Volume: 42,155 Pricing delayed 20 minutes December 15, 2017 03 59 PM

Press Releases

Latest Presentation

Check back later.

Recent Events

Latest Financials

Annual Report